Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-001360-36Phase 2Completed
Phase 2, open-label trial of indocyanine green in upper extremity lymphedema (UEL) (2 arms), sponsored by Unité de Recherche en Lymphologie. Primary endpoint: Visualization of superficial lymphatic network in lymphedema patients. Started Aug 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-001360-36.